ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 492

‘It Felt Like I Was Walking on Rocks” Patients Share First Symptoms of RA

Pamela Sinicrope1, Dana Symons 2, Ahmad P. Tafti 1, Christi Patten 1, Martha Bock 1, Jon Tilburt 1, Cynthia Crowson 1, Elena Myasoedova 1, John Davis 1 and Kelly O'Neill 3, 1Mayo Clinic, Rochester, MN, 2Rheumatoid Patient Foundation, Inc., Rockford, MI, 3Rheumatoid Patient Foundation, Inc., Winter Springs, FL

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: diagnosis and patient

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: RA – Diagnosis, Manifestations, & Outcomes Poster I: Risk Factors, Predictors, & Prognosis

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Background: Although early diagnosis and treatment are pivotal for successful outcomes in rheumatoid arthritis (RA), a gap remains in our understanding of its earliest symptoms. Current diagnosis requires physician evaluation for joint involvement, serology, inflammatory markers and symptom duration to allow accumulation of at least 6 points by the 2010 ACR/EULAR criteria. Patients may experience symptoms not accounted for in the criteria, a discrepancy which could impede early identification of RA. Data on patient perceptions of early RA symptoms and first body parts affected could provide important information to help facilitate the earliest recognition of disease and enable earlier treatment. To examine first symptoms, a non-profit organization collaborated with an academic rheumatology center to describe early RA symptoms as reported by patients in their own words.

Methods: Methods: From 2009-2017, people with RA who visited an RA-specific blog site or Facebook page were asked to describe their first RA symptom. Responses were extracted and de-identified.  Data collected included: date of response, text of response, and source. Responses from moderators and those who said they did not have RA, or who shared unrelated information were not included in the analysis; responses from the same person were combined. Content analysis was performed to identify themes of response and to tabulate: 1) very first symptom reported; 2) number of symptoms reported per respondent (1-4+), 3) data source (RA patient or other), and 4) length or ease of diagnosis experience.

Results: Results: 724 unique responses (99% RA patients self-reporting), 564 (77%) from the blog and 160 (23%) from Facebook were reviewed.  People with RA reported 37 different first symptoms, with 83.3% reporting a symptom outside of the hand(s), with feet (24.7%), hands (16.7%), knees (8.7%), fatigue (7.9%) and wrists (4.7%) being most common.  When categorizing first reported symptom, we found the top four were: 1) small joints (51.4%), 2) large joints (16.7%), 3) general (e.g. fatigue, pain) (8.7%), and 4) extra articular (e.g. pleurisy, iritis) (7.9%)    Overall, we found that among those describing the number and pattern of first symptoms (from 1-4+), the majority reported more than four (50.6%).  For example, one respondent wrote: “My eyes were my first symptom, followed by my feet, spine then ankles…my GP [general practitioner] continually said ‘no not RA’, that affects the hands first.” Themes included in responses were: 1) first symptom(s) and co-morbidities; 2) timing of symptoms to diagnosis/treatment, including pattern of onset and barriers; 3) life events surrounding symptoms (e.g. illness, accident); 4) patient/physician experience, among others.

Conclusion: Conclusions: Results show people with RA report a wide variety of first symptoms that do not always include hands or joints with varying patterns of onset over time.  Such findings could provide valuable information to help patients and physicians decrease the time between diagnosis and treatment by considering the possibility of more non-traditional RA presentations.   


Figure 1

Figure 1: Frequency of Top Patient-Reported First Symptoms -N=724-


Table 1

Table 1: Quotes Illustrating Themes Related to Patient-Reported First RA Symptoms


Disclosure: P. Sinicrope, None; D. Symons, None; A. P. Tafti, None; C. Patten, None; M. Bock, None; J. Tilburt, None; C. Crowson, None; E. Myasoedova, Pfizer, 2; J. Davis, None; K. O'Neill, None.

To cite this abstract in AMA style:

Sinicrope P, Symons D, P. Tafti A, Patten C, Bock M, Tilburt J, Crowson C, Myasoedova E, Davis J, O'Neill K. ‘It Felt Like I Was Walking on Rocks” Patients Share First Symptoms of RA [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/it-felt-like-i-was-walking-on-rocks-patients-share-first-symptoms-of-ra/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/it-felt-like-i-was-walking-on-rocks-patients-share-first-symptoms-of-ra/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology